Xtant Medical Announces Launch of SimpliGraft(TM) and SimpliMax(TM) for Chronic and Acute Wounds

Stock Information for Surgalign Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Surgalign Holdings Inc.

Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance
Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024
Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024
Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial
Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference
Xtant Medical to Participate in Upcoming Investor Conferences
Xtant Medical to Participate in Upcoming Investor Conferences

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.